Drugs / siRNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07596628 | Jun 2026 → Dec 2027 expected | keloid formation | Ong Kim Yao | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | siRNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07596628 ↗ |
| Modality | Small interfering RNA (siRNA) | “Small interfering RNA (siRNA) Microneedle Patches” NCT07596628 ↗ |
| Route | Other | “to enhance transcutaneous drug delivery” NCT07596628 ↗ |
| Target | SPARC | “These siRNA nanoplexes targeting SPARC mRNA” NCT07596628 ↗ |